Literature DB >> 10381028

Questions you didn't ask? COOP/WONCA Charts in clinical work and research. World Organization of Colleges, Academies and Academic Associations of General Practitioners/Family Physicists.

B G Bentsen1, B Natvig, M Winnem.   

Abstract

OBJECTIVE: COOP/WONCA Functional Assessment Charts are widely in use in research and clinical work. They originally evolved from Dartmouth COOP Functional Assessment Charts. Our objective is to describe our experiences with COOP/WONCA Charts and to provide data on reliability and reference data from a normal population.
METHOD: A test-retest study comprising 40 randomly selected patients attending GPs' surgeries was conducted. Eight GPs took part in this study. The response rate for the questionnaire was 100%. In a second study, 245 asthma patents who consulted 53 different GPs were consecutively included; 171 of these repeated completion of the charts after 6 months. Mean scores from a random sample of 2864 persons in the total population of the municipality of Ullensaker in Norway are given as reference values. There was a postal return rate of 64%. RESULTS AND
CONCLUSIONS: The reliability of the charts is good, and nine out of ten of the patients gave clinically meaningful answers after 2-3 days. The scores of the 171 asthma patients were nearly identical after 6 months. The reference values are presented. A standardized method for reliability testing is discussed, and the use of COOP/WONCA Functional Assessment Charts is commented on.

Entities:  

Mesh:

Year:  1999        PMID: 10381028     DOI: 10.1093/fampra/16.2.190

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  23 in total

Review 1.  A systematic review: how to choose appropriate health-related quality of life (HRQOL) measures in routine general practice?

Authors:  Tian-Hui Chen; Lu Li; Michael M Kochen
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

2.  Measurement properties of the Dizziness Handicap Inventory by cross-sectional and longitudinal designs.

Authors:  Anne-Lise Tamber; Kjersti T Wilhelmsen; Liv Inger Strand
Journal:  Health Qual Life Outcomes       Date:  2009-12-21       Impact factor: 3.186

Review 3.  Pharmaceutical care and health related quality of life outcomes over the past 25 years: Have we measured dimensions that really matter?

Authors:  Mohammed A Mohammed; Rebekah J Moles; Timothy F Chen
Journal:  Int J Clin Pharm       Date:  2018-01-10

4.  COOP/WONCA charts as a screen for mental disorders in primary care.

Authors:  Joao Mazzoncini de Azevedo-Marques; Antonio Waldo Zuardi
Journal:  Ann Fam Med       Date:  2011 Jul-Aug       Impact factor: 5.166

5.  Factors predicting work ability following multidisciplinary rehabilitation for chronic musculoskeletal pain.

Authors:  Monica Lillefjell; Steinar Krokstad; Geir Arild Espnes
Journal:  J Occup Rehabil       Date:  2006-12

6.  Gender differences in psychosocial influence and rehabilitation outcomes for work-disabled individuals with chronic musculoskeletal pain.

Authors:  Monica Lillefjell
Journal:  J Occup Rehabil       Date:  2006-12

7.  Evaluation of patient outcomes in an area where prescribing of anticholinergic antidepressants was influenced by academic detailing.

Authors:  M E C van Eijk; S V Belitser; A J Porsius; A de Boer
Journal:  Pharm World Sci       Date:  2002-08

8.  Reliability and validity of the COOP/WONCA health status measure in patients with chronic obstructive pulmonary disease.

Authors:  K Stavem; H Jodalen
Journal:  Qual Life Res       Date:  2002-09       Impact factor: 4.147

9.  Symptom load and functional status: results from the Ullensaker population study.

Authors:  Dag Bruusgaard; Hedda Tschudi-Madsen; Camilla Ihlebæk; Yusman Kamaleri; Bård Natvig
Journal:  BMC Public Health       Date:  2012-12-18       Impact factor: 3.295

10.  Functional ability in a population: normative survey data and reliability for the ICF based Norwegian Function Assessment Scale.

Authors:  Nina Østerås; Søren Brage; Andrew Garratt; Jurate Saltyte Benth; Bård Natvig; Pål Gulbrandsen
Journal:  BMC Public Health       Date:  2007-10-03       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.